Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (321-330 of 760) with videos related to

Pageof 76
Sort By:
Journal of the American College of Cardiology|March 16, 2005
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studiesRaúl Moreno, Cristina Fernández, Rosana Hernández, et al.
Circulation|February 21, 2002
Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive proteinElisabetta Rossi, Luigi M Biasucci, Franco Citterio, et al.
JACC. Cardiovascular Interventions|August 13, 2025
Aspirin or P2Y<sub>12</sub> Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary SyndromesClaudio Laudani, Daniele Giacoppo, Giovanni Occhipinti, et al.
JACC. Cardiovascular Interventions|June 24, 2014
Operator radiation exposure and physical discomfort during a right versus left radial approach for coronary interventions: a randomized evaluationHerman Kado, Ambar M Patel, Siva Suryadevara, et al.
Journal of the American College of Cardiology|February 13, 2016
Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCIDominick J Angiolillo, Francesco Franchi, Ron Waksman, et al.
Journal of the American Heart Association|October 9, 2025
Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary SyndromeAntonio Landi, Andrea Zito, Mandeep Singh, et al.
Thrombosis and Haemostasis|October 10, 2025
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled StudiesLuis Ortega-Paz, Yasushi Ueki, Claudio Laudani, et al.
Journal of the American College of Cardiology|November 20, 2020
Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 TrialKatharina Mayer, Dario Bongiovanni, Vincent Karschin, et al.
Expert Review of Clinical Pharmacology|December 1, 2022
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implicationsMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Circulation. Cardiovascular Interventions|September 23, 2010
Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover studyJosé L Ferreiro, Masafumi Ueno, Davide Capodanno, et al.
Pageof 76

Showing results (321-330 of 760) with videos related to

Sort By:
Pageof 76
Journal of the American College of Cardiology|March 16, 2005
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studiesRaúl Moreno, Cristina Fernández, Rosana Hernández, et al.
Circulation|February 21, 2002
Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive proteinElisabetta Rossi, Luigi M Biasucci, Franco Citterio, et al.
JACC. Cardiovascular Interventions|August 13, 2025
Aspirin or P2Y<sub>12</sub> Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary SyndromesClaudio Laudani, Daniele Giacoppo, Giovanni Occhipinti, et al.
JACC. Cardiovascular Interventions|June 24, 2014
Operator radiation exposure and physical discomfort during a right versus left radial approach for coronary interventions: a randomized evaluationHerman Kado, Ambar M Patel, Siva Suryadevara, et al.
Journal of the American College of Cardiology|February 13, 2016
Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCIDominick J Angiolillo, Francesco Franchi, Ron Waksman, et al.
Journal of the American Heart Association|October 9, 2025
Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary SyndromeAntonio Landi, Andrea Zito, Mandeep Singh, et al.
Thrombosis and Haemostasis|October 10, 2025
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled StudiesLuis Ortega-Paz, Yasushi Ueki, Claudio Laudani, et al.
Journal of the American College of Cardiology|November 20, 2020
Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 TrialKatharina Mayer, Dario Bongiovanni, Vincent Karschin, et al.
Expert Review of Clinical Pharmacology|December 1, 2022
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implicationsMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
Circulation. Cardiovascular Interventions|September 23, 2010
Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover studyJosé L Ferreiro, Masafumi Ueno, Davide Capodanno, et al.
Pageof 76